Safety, Tolerability, QTc Evaluation, and Pharmacokinetics of Single and Multiple Doses of Enzastaurin HCl (LY317615), a Protein Kinase C-{beta} Inhibitor, in Healthy Subjects.
- Published in:
- 2007
- By:
- Publication type:
- Journal Article
Works by Sinha VP
Results: 2
1
2
A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes.
- Published in:
- 2012
- By:
- Publication type:
- journal article